{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:41:49Z","timestamp":1790433709233,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.08.010","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T22:00:01Z","timestamp":1156543201000},"page":"741-750","source":"Crossref","is-referenced-by-count":29,"title":["An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge"],"prefix":"10.1016","volume":"25","author":[{"given":"Amy","family":"Palin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anasuya","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rema","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Senina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Perlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2006.08.010_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1286-4579(01)01515-5","article-title":"Molecular insights into the history of plague","volume":"4","author":"Drancourt","year":"2002","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2006.08.010_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.010_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s100960050237","article-title":"Yersiniosis II: the pathogenesis of Yersinia infections","volume":"18","author":"Koornhof","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2006.08.010_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/MMBR.25.3.249-261.1961","article-title":"Pneumonic plague","volume":"25","author":"Meyer","year":"1961","journal-title":"Bacteriol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.010_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multidrug resistance in Yersinia pestis mediated by a transferable plasmid","volume":"337","author":"Galimand","year":"1997","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.vaccine.2006.08.010_bib6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1359-6446(03)02847-2","article-title":"Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents","volume":"8","author":"Greenfield","year":"2003","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.vaccine.2006.08.010_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2006.08.010_bib8","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/IAI.67.4.1922-1928.1999","article-title":"Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice","volume":"67","author":"Benner","year":"1999","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.08.010_bib9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1128\/IAI.73.3.1532-1542.2005","article-title":"Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis","volume":"73","author":"Philipovskiy","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.08.010_bib10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1128\/IAI.70.3.1453-1460.2002","article-title":"Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis","volume":"70","author":"Du","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2006.08.010_bib11","first-page":"75","article-title":"Antigen F1 from Yersinia pestis forms aqueous channels in lipid bilayer membranes","volume":"25","author":"Rodrigues","year":"1992","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"10.1016\/j.vaccine.2006.08.010_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/infdis\/126.3.235","article-title":"Effects of fraction I from Yersinia pestis on phagocytosis in vitro","volume":"126","author":"Williams","year":"1972","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2006.08.010_bib13","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/clinids\/21.Supplement_2.S178","article-title":"Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis","volume":"21","author":"Friedlander","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2006.08.010_bib14","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1128\/IAI.65.9.3954-3957.1997","article-title":"Failure to detect binding of LcrH to the V antigen of Yersinia pestis","volume":"65","author":"Fields","year":"1997","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.010_bib15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1365-2958.1999.01408.x","article-title":"The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation","volume":"32","author":"Pettersson","year":"1999","journal-title":"Mol Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.010_bib16","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1128\/jb.171.10.5646-5653.1989","article-title":"Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis","volume":"171","author":"Price","year":"1989","journal-title":"J Bacteriol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.010_bib17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.20020908","article-title":"Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression","volume":"196","author":"Sing","year":"2002","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.010_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/IAI.51.2.445-454.1986","article-title":"Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins","volume":"51","author":"Straley","year":"1986","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2006.08.010_bib19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice","volume":"58","author":"Anderson","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.vaccine.2006.08.010_bib20","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/IAI.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2006.08.010_bib21","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1128\/IAI.64.6.2180-2187.1996","article-title":"Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge","volume":"64","author":"Andrews","year":"1996","journal-title":"Infect Immun"},{"issue":"28","key":"10.1016\/j.vaccine.2006.08.010_bib22","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1016\/S0264-410X(00)00128-6","article-title":"Protection studies following bronchopulmonary and intramuscular immunisation with Yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy","volume":"18","author":"Eyles","year":"2000","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2006.08.010_bib23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.010_bib24","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.63.8.2854-2858.1995","article-title":"Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.08.010_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-695X.1998.tb01168.x","article-title":"Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity","volume":"21","author":"Miller","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.010_bib26","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol Prog"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2006.08.010_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.010_bib28","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2006.08.010_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0264-410X(00)00159-6","article-title":"A single dose sub-unit vaccine protects against pneumonic plague","volume":"19","author":"Williamson","year":"2000","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2006.08.010_bib30","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and systemic immune response to a microencapsulated sub-unit vaccine for plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.010_bib31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.vaccine.2003.09.020","article-title":"Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen","volume":"22","author":"Garmory","year":"2004","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2006.08.010_bib32","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2006.08.010_bib33","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/S0264-410X(02)00232-3","article-title":"Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague","volume":"20","author":"Williamson","year":"2002","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.010_bib34","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vaccine.2006.08.010_bib35","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/JVI.70.4.2318-2323.1996","article-title":"The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus","volume":"70","author":"Schnell","year":"1996","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.010_bib36","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1128\/JVI.71.8.5982-5989.1997","article-title":"High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses","volume":"71","author":"Kretzschmar","year":"1997","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.010_bib37","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.08.010_bib38","series-title":"Fields\u2019 virology","first-page":"1137","article-title":"Rhabdoviruses","author":"Dietzschold","year":"1996"},{"key":"10.1016\/j.vaccine.2006.08.010_bib39","series-title":"Fields\u2019 virology","article-title":"Rhabdoviridae: the viruses and their replication","author":"Rose","year":"2001"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.08.010_bib40","first-page":"53","article-title":"Cell-mediated immunity to vesicular stomatitis virus infections in mice","volume":"46","author":"Zinkernagel","year":"1978","journal-title":"Exp Cell Biol"},{"issue":"22","key":"10.1016\/j.vaccine.2006.08.010_bib41","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1128\/JVI.75.22.11079-11087.2001","article-title":"Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge","volume":"75","author":"Kahn","year":"2001","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2006.08.010_bib42","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1128\/JVI.76.17.8900-8909.2002","article-title":"Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease","volume":"76","author":"Reuter","year":"2002","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.08.010_bib43","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","article-title":"Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge","volume":"72","author":"Roberts","year":"1998","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.010_bib44","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.08.010_bib45","first-page":"537","article-title":"Development of a new vaccine for the prevention of lassa fever","volume":"2","author":"Geisbert","year":"2006","journal-title":"PLOS Med"},{"issue":"7","key":"10.1016\/j.vaccine.2006.08.010_bib46","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.010_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine","volume":"340","author":"Kapadia","year":"2005","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2006.08.010_bib48","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/JVI.78.6.3196-3199.2004","article-title":"Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein","volume":"78","author":"Roberts","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.010_bib49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.010_bib50","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/JVI.74.10.4652-4657.2000","article-title":"Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies","volume":"74","author":"Schlereth","year":"2000","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.08.010_bib51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/aid.2004.20.989","article-title":"Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes","volume":"20","author":"Egan","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.010_bib52","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.78.8.3930-3940.2004","article-title":"Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol","volume":"78","author":"Ramsburg","year":"2004","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2006.08.010_bib53","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1128\/JVI.79.24.15043-15053.2005","article-title":"A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals","volume":"79","author":"Ramsburg","year":"2005","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2006.08.010_bib54","doi-asserted-by":"crossref","first-page":"10903","DOI":"10.1128\/JVI.74.23.10903-10910.2000","article-title":"Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1","volume":"74","author":"Rose","year":"2000","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2006.08.010_bib55","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1073\/pnas.83.21.8122","article-title":"Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase","volume":"83","author":"Fuerst","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.vaccine.2006.08.010_bib56","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/IAI.65.11.4476-4482.1997","article-title":"Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization","volume":"65","author":"Hill","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.08.010_bib57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4049\/jimmunol.91.2.179","article-title":"Biosynthesis and purification of V and W antigen in Pasteurella pestis","volume":"91","author":"Lawton","year":"1963","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.010_bib58","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/IAI.62.10.4192-4201.1994","article-title":"Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide","volume":"62","author":"Motin","year":"1994","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.08.010_bib59","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.4049\/jimmunol.133.4.2226","article-title":"Roles of V antigen in promoting virulence and immunity in yersiniae","volume":"133","author":"Une","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.08.010_bib60","first-page":"179","article-title":"Roles of V antigen in promoting virulence in Yersiniae","volume":"9","author":"Une","year":"1987","journal-title":"Contrib Microbiol Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.08.010_bib61","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.010_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-695X.1999.tb01229.x","article-title":"The SCID\/Beige mouse as a model to investigate protection against Yersinia pestis","volume":"23","author":"Green","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.08.010_bib63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(99)00197-2","article-title":"Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits","volume":"63","author":"Eyles","year":"2000","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.010_bib64","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.vaccine.2005.09.052","article-title":"Intranasal Protollin trade mark\/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection","volume":"24","author":"Jones","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.010_bib65","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"Honko","year":"2006","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2006.08.010_bib66","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1128\/IAI.71.7.3673-3681.2003","article-title":"Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen)","volume":"71","author":"Brubaker","year":"2003","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.010_bib67","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/IAI.63.8.3021-3029.1995","article-title":"Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization","volume":"63","author":"Nakajima","year":"1995","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.010_bib68","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1128\/IAI.73.8.5152-5159.2005","article-title":"LcrV plague vaccine with altered immunomodulatory properties","volume":"73","author":"Overheim","year":"2005","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T16:50:56Z","timestamp":1683564656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06009522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06009522"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.08.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}